Clinical Trial Detail

NCT ID NCT04025879
Title A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

lung non-small cell carcinoma

Therapies

Carboplatin + Cisplatin + Nivolumab + Paclitaxel + Pemetrexed Disodium

Carboplatin + Cisplatin + Paclitaxel + Pemetrexed Disodium

Age Groups: adult senior

No variant requirements are available.